A Mark Colb is a notable inventor based in West Roxbury, MA (US). He has made significant contributions to the field of vascular medicine, particularly in techniques for re-endothelializing damaged arteries. With a total of 2 patents to his name, Colb's work is paving the way for advancements in medical treatments.

Latest Patents

Colb's latest patents focus on the "Endothelialization of vascular surfaces." This invention involves a technique for re-endothelializing an artery whose endothelial layer has been compromised due to balloon angioplasty. The method includes introducing a bispecific antibody into the bloodstream of a patient before the angioplasty procedure. This antibody has two antigen binding sites: one directed against a surface marker common to both endothelial progenitor cells (EPCs) and endothelial cells (ECs), and the other against a subendothelial epitope. By binding a substantial percentage of circulating EPCs and ECs, the bispecific antibodies facilitate the coverage of the exposed subendothelium after angioplasty, promoting healing through proliferation and differentiation.

Career Highlights

Throughout his career, A Mark Colb has focused on innovative solutions in vascular medicine. His research and inventions have contributed to improved patient outcomes in procedures involving arterial damage. His expertise in the field has established him as a respected figure among his peers.

Collaborations

Colb has worked alongside notable professionals, including his coworker Herman K Gold. Their collaboration has likely fostered advancements in their shared field of expertise.

Conclusion

A Mark Colb's contributions to vascular medicine through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the field and offers hope for enhanced patient care in the future.